Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call
Rhea-AI Summary
Strata Critical Medical (Nasdaq: SRTA) will release financial results for the first quarter ended March 31, 2026 on Wednesday, May 6, 2026 before market open. The company will host a conference call the same day at 8:00 AM ET to discuss results and answer questions.
Hosts will be Co-CEOs Melissa Tomkiel and Will Heyburn. Investors can register to join live and receive dial-in/PIN; an audio-only webcast will be available on the investor website and a replay will be accessible for one year.
Positive
- None.
Negative
- None.
News Market Reaction – SRTA
In the Apr 21 session, SRTA gained 5.97%, reflecting a notable positive market reaction. Argus tracked a peak move of +3.8% during that session. Our momentum scanner triggered 16 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 10 | Earnings call scheduling | Neutral | -2.2% | Set date and time for Q4 2025 earnings release and conference call. |
| Oct 09 | Earnings call scheduling | Neutral | -6.0% | Announced Q3 2025 earnings release date and related investor conference call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior 'conferences,earnings' scheduling releases for SRTA were followed by negative one-day moves, with an average move of about -4.1% across two events.
Over the last several months, Strata Critical Medical has regularly communicated around earnings timing and investor events. A prior 'conferences,earnings' notice on Feb 10, 2026 about the Q4 2025 call preceded a -2.2% move, while a similar Q3 2025 scheduling release on Oct 9, 2025 saw shares down -5.99%. Alongside these, the company reported strong Q4 2025 and full-year 2025 revenue growth and raised 2026 guidance, plus expanded credit capacity to support acquisitions. Today’s Q1 2026 call announcement fits that ongoing communication pattern.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the first quarter ended March 31, 2026 on Wednesday May 6, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata’s Co-Chief Executive Officer and Chief Financial Officer, and will include a question-and-answer session for call participants.
To join the live call, please register here. Upon registration, a dial-in and unique PIN will be provided to join the call.
An audio-only webcast of the call may be accessed from the Investors section of the Company’s website at https://ir.stratacritical.com/ or by registering at the link here. A replay of the webcast will be available for one year.
About Strata Critical Medical, Inc.
Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.
Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
For more information, visit www.srta.com.
Contacts
Mathew Schneider
investors@srta.com
